As of 2025-07-02, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (18.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.51 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -824.2%.
The range of the Relative Valuation is (18.85) - (18.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.5x - 31.7x | 29.5x |
| Forward P/E multiples | 26.1x - 28.8x | 27.4x |
| Fair Price | (18.85) - (18.38) | (18.18) |
| Upside | -850.9% - -832.1% | -824.2% |
| Date | P/E |
| 2025-07-01 | -3.93 |
| 2025-06-30 | -3.77 |
| 2025-06-27 | -3.87 |
| 2025-06-26 | -3.72 |
| 2025-06-25 | -3.55 |
| 2025-06-24 | -3.49 |
| 2025-06-23 | -3.30 |
| 2025-06-20 | -3.22 |
| 2025-06-18 | -3.15 |
| 2025-06-17 | -3.27 |
| 2025-06-16 | -3.38 |
| 2025-06-13 | -3.33 |
| 2025-06-12 | -3.54 |
| 2025-06-11 | -3.57 |
| 2025-06-10 | -3.38 |
| 2025-06-09 | -3.57 |
| 2025-06-06 | -3.74 |
| 2025-06-05 | -3.40 |
| 2025-06-04 | -3.46 |
| 2025-06-03 | -3.47 |
| 2025-06-02 | -3.33 |
| 2025-05-30 | -3.52 |
| 2025-05-29 | -3.71 |
| 2025-05-28 | -3.46 |
| 2025-05-27 | -3.49 |
| 2025-05-23 | -3.47 |
| 2025-05-22 | -3.59 |
| 2025-05-21 | -3.52 |
| 2025-05-20 | -3.76 |
| 2025-05-19 | -3.40 |
| 2025-05-16 | -3.29 |
| 2025-05-15 | -3.07 |
| 2025-05-14 | -3.10 |
| 2025-05-13 | -3.22 |
| 2025-05-12 | -3.32 |
| 2025-05-09 | -3.10 |
| 2025-05-08 | -3.24 |
| 2025-05-07 | -3.32 |
| 2025-05-06 | -3.18 |
| 2025-05-05 | -3.32 |
| 2025-05-02 | -3.24 |
| 2025-05-01 | -3.18 |
| 2025-04-30 | -3.16 |
| 2025-04-29 | -3.24 |
| 2025-04-28 | -3.15 |
| 2025-04-25 | -3.20 |
| 2025-04-24 | -3.24 |
| 2025-04-23 | -3.29 |
| 2025-04-22 | -3.02 |
| 2025-04-21 | -2.77 |